A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2

Bone morphogenetic protein-2 (BMP-2) is currently the only Food and Drug Administration (FDA)-approved osteoinductive growth factor used as a bone graft substitute. However, with increasing clinical use of BMP-2, a growing and well-documented side effect profile has emerged. This includes postoperat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Tissue Eng Part B Rev
Autors principals: James, Aaron W., LaChaud, Gregory, Shen, Jia, Asatrian, Greg, Nguyen, Vi, Zhang, Xinli, Ting, Kang, Soo, Chia
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2016
Matèries:
Review Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964756/
https://ncbi.nlm.nih.gov/pubmed/26857241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ten.teb.2015.0357
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars